These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 3380582

  • 1. Microbiologic characteristics of exfoliative toxin-producing Staphylococcus aureus.
    Murono K, Fujita K, Yoshioka H.
    Pediatr Infect Dis J; 1988 May; 7(5):313-5. PubMed ID: 3380582
    [Abstract] [Full Text] [Related]

  • 2. Producibility of exfoliative toxin and staphylococcal coagulase types of Staphylococcus aureus strains isolated from skin infections and atopic dermatitis.
    Kanzaki H, Ueda M, Morishita Y, Akiyama H, Arata J, Kanzaki S.
    Dermatology; 1997 May; 195(1):6-9. PubMed ID: 9267729
    [Abstract] [Full Text] [Related]

  • 3. Staphylococcal scalded skin syndrome in two immunocompetent adults caused by exfoliatin B-producing Staphylococcus aureus.
    Opal SM, Johnson-Winegar AD, Cross AS.
    J Clin Microbiol; 1988 Jul; 26(7):1283-6. PubMed ID: 3137245
    [Abstract] [Full Text] [Related]

  • 4. Screening of clinical S. aureus-isolates for the production of exfoliative toxin. A methodological study.
    Elsner P, Hartmann AA, Lenz W, Brandis H.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Oct; 260(2):216-20. PubMed ID: 3936308
    [Abstract] [Full Text] [Related]

  • 5. Clinical manifestations of staphylococcal scalded-skin syndrome depend on serotypes of exfoliative toxins.
    Yamasaki O, Yamaguchi T, Sugai M, Chapuis-Cellier C, Arnaud F, Vandenesch F, Etienne J, Lina G.
    J Clin Microbiol; 2005 Apr; 43(4):1890-3. PubMed ID: 15815014
    [Abstract] [Full Text] [Related]

  • 6. Two serotypes of exfoliatin and their distribution in staphylococcal strains isolated from patients with scalded skin syndrome.
    Kondo I, Sakurai S, Sarai Y, Futaki S.
    J Clin Microbiol; 1975 May; 1(5):397-400. PubMed ID: 126250
    [Abstract] [Full Text] [Related]

  • 7. An inhibitor of Staphylococcus aureus exfoliative toxin.
    Al-Sulami AA, Al-Rubiay KK, Affat AM.
    East Mediterr Health J; 2001 May; 7(1-2):121-7. PubMed ID: 12596961
    [Abstract] [Full Text] [Related]

  • 8. Detection of staphylococcal exfoliative toxin by slide latex agglutination.
    Murono K, Fujita K, Yoshioka H.
    J Clin Microbiol; 1988 Feb; 26(2):271-4. PubMed ID: 3343322
    [Abstract] [Full Text] [Related]

  • 9. Association between lesional or non lesional S. aureus strains from patients with impetigo and exfoliative toxin production. No association with SmaI PFGE patterns.
    Capoluongo E, Giglio A, Belardi M, Leonetti F, Frasca A, Giannetti A, Ameglio F.
    New Microbiol; 2000 Jan; 23(1):21-7. PubMed ID: 10946402
    [Abstract] [Full Text] [Related]

  • 10. Exfoliative toxin production by Staphylococcus aureus strains isolated from animals and human beings in Nigeria.
    Adesiyun AA, Lenz W, Schaal KP.
    Microbiologica; 1991 Oct; 14(4):357-62. PubMed ID: 1775093
    [Abstract] [Full Text] [Related]

  • 11. Importance of exfoliatin toxin A production by Staphylococcus aureus strains isolated from clustered epidemics of neonatal pustulosis.
    Kaplan MH, Chmel H, Hsieh HC, Stephens A, Brinsko V.
    J Clin Microbiol; 1986 Jan; 23(1):83-91. PubMed ID: 3700612
    [Abstract] [Full Text] [Related]

  • 12. Molecular typing of exfoliative toxin-producing Staphylococcus aureus strains involved in epidermolytic infections.
    Růzicková V, Pantůcek R, Petrás P, Doskar J, Sedlácek I, Rosypal S.
    Int J Med Microbiol; 2003 Feb; 292(7-8):541-5. PubMed ID: 12635937
    [Abstract] [Full Text] [Related]

  • 13. [Isolation and purification of biologically active substances from Staphylococcus aureus isolated from a skin disease. II. Isolation and purification of exfoliative toxin].
    Sugai M.
    Hiroshima Daigaku Shigaku Zasshi; 1987 Dec; 19(2):402-8. PubMed ID: 3504874
    [No Abstract] [Full Text] [Related]

  • 14. Toxin involvement in staphylococcal scalded skin syndrome.
    Lina G, Gillet Y, Vandenesch F, Jones ME, Floret D, Etienne J.
    Clin Infect Dis; 1997 Dec; 25(6):1369-73. PubMed ID: 9431380
    [Abstract] [Full Text] [Related]

  • 15. Emergence of Staphylococcus aureus carrying multiple drug resistance genes on a plasmid encoding exfoliative toxin B.
    Hisatsune J, Hirakawa H, Yamaguchi T, Fudaba Y, Oshima K, Hattori M, Kato F, Kayama S, Sugai M.
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6131-40. PubMed ID: 24080652
    [Abstract] [Full Text] [Related]

  • 16. [Causative agent of impetigo: staphylococcal exfoliative toxin and regulation of the toxin production in Staphylococcus aureus].
    Sakurai S.
    Nihon Saikingaku Zasshi; 1996 Aug; 51(3):813-22. PubMed ID: 8840812
    [No Abstract] [Full Text] [Related]

  • 17. Regulatory mechanism for exfoliative toxin production in Staphylococcus aureus.
    Kato F, Kadomoto N, Iwamoto Y, Bunai K, Komatsuzawa H, Sugai M.
    Infect Immun; 2011 Apr; 79(4):1660-70. PubMed ID: 21282415
    [Abstract] [Full Text] [Related]

  • 18. An exfoliative toxin A-converting phage isolated from Staphylococcus aureus strain ZM.
    Yoshizawa Y, Sakurada J, Sakurai S, Machida K, Kondo I, Masuda S.
    Microbiol Immunol; 2000 Apr; 44(3):189-91. PubMed ID: 10789506
    [Abstract] [Full Text] [Related]

  • 19. [A case of staphylococcal scalded skin syndrome caused by exfoliative toxin-B producing MRSA].
    Yokota S, Imagawa T, Katakura S, Mitsuda T, Arai K.
    Kansenshogaku Zasshi; 1996 Feb; 70(2):206-10. PubMed ID: 8851394
    [Abstract] [Full Text] [Related]

  • 20. Bullous impetigo in children infected with methicillin-resistant Staphylococcus aureus alone or in combination with methicillin-susceptible S. aureus: analysis of genetic characteristics, including assessment of exfoliative toxin gene carriage.
    Shi D, Higuchi W, Takano T, Saito K, Ozaki K, Takano M, Nitahara Y, Yamamoto T.
    J Clin Microbiol; 2011 May; 49(5):1972-4. PubMed ID: 21430094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.